European Journal of Pharmacology 1998-08-21

Tenidap enhances P2Z/P2X7 receptor signalling in macrophages.

J M Sanz, P Chiozzi, F Di Virgilio

Index: Eur. J. Pharmacol. 355(2-3) , 235-44, (1998)

Full Text: HTML

Abstract

Tenidap is an anti-inflammatory drug whose mechanism of action is not fully understood. It has been shown to block plasma membrane anion transport and to decrease release of interleukin-1beta, probably via the inhibition of interleukin-1beta converting enzyme. In the present study we showed that: (a) tenidap increases the sensitivity of mouse macrophages to cytotoxic effects mediated by extracellular ATP; (b) tenidap increases lucifer yellow uptake through the macrophage ATP receptor; (c) pretreatment with oxidised ATP, a blocker of the P2Z/P2X7 receptor, inhibits cytotoxicity and lucifer yellow uptake due to the combined effects of ATP and tenidap; (d) macrophages lacking the P2Z/P2X7 receptor are resistant to the synergistic effect of tenidap and ATP. The results suggest that tenidap synergises with extracellular ATP for activation of the P2Z/P2X7 receptor.

Related Compounds

  • CP-66248

Related Articles:

Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.

1998-03-01

[Clin. Exp. Immunol. 111(3) , 588-96, (1998)]

The renal Na-HCO3-cotransporter expressed in Xenopus laevis oocytes: inhibition by tenidap and benzamil and effect of temperature on transport rate and stoichiometry.

2001-08-01

[Pflugers Arch. 442(5) , 709-17, (2001)]

Tenidap: not just another NSAID?

1996-02-01

[Ann. Rheum. Dis. 55(2) , 79-82, (1996)]

Tenidap, an anti-inflammatory agent, inhibits DNA and collagen syntheses, depresses cell proliferation, and lowers intracellular pH in cultured human gingival fibroblasts.

2002-02-01

[J. Pharmacol. Exp. Ther. 300(2) , 668-72, (2002)]

Tenidap, a novel anti-inflammatory agent, is an opener of the inwardly rectifying K+ channel hKir2.3.

2002-01-25

[Eur. J. Pharmacol. 435(2-3) , 153-60, (2002)]

More Articles...